Everpure, Inc. ⋅ 10-Q ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 Victoria's Secret & Co. ⋅ 10-Q ⋅ 6/5 PVH CORP. /DE/ ⋅ 10-Q ⋅ 6/5 ABM INDUSTRIES INC /DE/ ⋅ 10-Q ⋅ 6/5 Quanex Building Products CORP ⋅ 10-Q ⋅ 6/5 SHOE CARNIVAL INC ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 Victoria's Secret & Co. ⋅ 10-Q ⋅ 6/5 PVH CORP. /DE/ ⋅ 10-Q ⋅ 6/5 ABM INDUSTRIES INC /DE/ ⋅ 10-Q ⋅ 6/5 Quanex Building Products CORP ⋅ 10-Q ⋅ 6/5 SHOE CARNIVAL INC ⋅ 10-Q ⋅ 6/5

AbbVie Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: (847) 932-7900

CIK: 0001551152
EIN: 320375147
State Location: IL
State of Inc.: DE

NYSE:ABBV

Form: SCHEDULE 13G

Filing Date: 29 Apr 2026
Report Date:
Accepted: 29 Apr 2026 02:37 p.m.
Accession Number: 0002100119-26-000126

Act: 34
File Number: 005-87819
Film Number: 26916985

Documents

Primary Document

Accepted: 29 Apr 2026 02:37 p.m.

0002100119-26-000126-index-headers.html

Last Modified: 29 Apr 2026 02:37 p.m.

0002100119-26-000126-index.html

Last Modified: 29 Apr 2026 02:37 p.m.

0002100119-26-000126.txt

Last Modified: 29 Apr 2026 02:37 p.m.

primary_doc.xml

Last Modified: 29 Apr 2026 02:37 p.m.